data_1qnz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qnz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' H' H ' 113' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.368 0.128 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 114' ' ' VAL . . . . . 0.551 ' CG2' ' CD1' ' H' ' 139' ' ' TYR . 3.2 p -136.8 155.55 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 115' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -169.74 143.23 2.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt -106.23 89.83 3.18 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 117' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -86.1 88.45 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 118' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' H' ' 134' ' ' CYS . 11.1 pt20 -92.6 153.77 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -138.24 122.3 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.27 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 120' ' ' GLY . . . . . 0.453 ' HA2' ' CE ' ' H' ' 132' ' ' MET . . . -166.02 45.05 0.27 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.165 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 121' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' H' ' 226' ' ' SER . . . -100.78 76.14 1.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 122' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -122.47 151.57 41.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.67 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 123' ' ' LEU . . . . . . . . . . . . . 58.3 tp -92.68 79.16 4.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.373 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 124' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.26 146.46 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.346 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 125' ' ' LYS . . . . . 0.439 ' CG ' ' HD2' ' H' ' 126' ' ' PRO . 40.8 ttmt -107.34 144.57 29.46 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.747 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 126' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' H' ' 125' ' ' LYS . 88.4 Cg_exo -47.23 114.89 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.45 2.1 . . . . 0.0 112.589 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 26.02 18.38 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.988 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.19 178.79 4.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.856 0.328 . . . . 0.0 111.17 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 129' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' H' ' 195' ' ' PHE . 63.6 m -142.61 92.62 2.43 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.836 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 130' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.38 130.9 40.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.495 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 131' ' ' LYS . . . . . 0.531 ' HE2' ' CD2' ' H' ' 192' ' ' TYR . 81.2 tttt -101.92 103.3 13.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.808 0.337 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 132' ' ' MET . . . . . 0.525 ' HB2' ' HB3' ' H' ' 193' ' ' LEU . 86.0 mtp -75.25 170.27 16.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 133' ' ' SER . . . . . . . . . . . . . 73.7 p -148.69 112.82 5.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.84 0.353 . . . . 0.0 111.773 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 134' ' ' CYS . . . . . 0.448 ' HB2' ' CH2' ' H' ' 148' ' ' TRP . 42.2 t -103.06 98.21 8.19 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.93 175.945 124.945 80.708 104.41 2.033 104.341 151.906 50.335 2 2 . 1 . 001 nuclear orig full ' H' H ' 135' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.81 149.2 34.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 136' ' ' ALA . . . . . 0.433 ' HB3' ' CD1' ' H' ' 139' ' ' TYR . . . -128.59 90.71 3.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.656 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 137' ' ' SER . . . . . . . . . . . . . 61.6 p -84.89 143.87 28.75 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 138' ' ' GLY . . . . . . . . . . . . . . . 65.45 25.02 71.2 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.098 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 139' ' ' TYR . . . . . 0.551 ' CD1' ' CG2' ' H' ' 114' ' ' VAL . 0.4 OUTLIER -109.94 155.96 21.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 140' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' H' ' 144' ' ' TYR . 47.3 m -90.35 -32.06 16.63 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 141' ' ' PHE . . . . . 0.496 ' CE2' ' HB3' ' H' ' 165' ' ' PRO . 11.0 t80 72.12 -76.07 0.07 Allowed 'General case' 0 C--N 1.347 0.469 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.603 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 142' ' ' THR . . . . . . . . . . . . . 72.6 p -50.87 -34.01 26.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 143' ' ' THR . . . . . 0.438 ' O ' ' HB3' ' P' ' 236' ' ' ARG . 50.7 m -85.74 -28.75 24.41 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 144' ' ' TYR . . . . . 0.402 ' CD1' ' HB ' ' H' ' 140' ' ' THR . 39.8 m-85 -105.71 92.75 6.46 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 145' ' ' PRO . . . . . 0.587 ' HD2' ' CZ ' ' P' ' 236' ' ' ARG . 24.5 Cg_endo -63.09 143.17 89.92 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.166 1.911 . . . . 0.0 110.939 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 146' ' ' ILE . . . . . 0.414 ' HA ' HG21 ' H' ' 210' ' ' ILE . 58.1 mt -106.91 138.44 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 112.152 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 147' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -119.49 146.38 45.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.97 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 148' ' ' TRP . . . . . 0.47 ' CD2' HD21 ' H' ' 193' ' ' LEU . 93.3 m95 -111.83 136.21 51.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 111.381 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 149' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' H' ' 206' ' ' TYR . 3.6 mpp? -120.97 126.4 49.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.025 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 150' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -103.55 119.26 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 151' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -111.15 84.66 1.97 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 152' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -60.31 108.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 110.455 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 153' ' ' HIS . . . . . 0.41 ' HB2' ' HD3' ' H' ' 155' ' ' LYS . 88.7 m-70 60.42 -146.45 0.47 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.047 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 154' ' ' GLY . . . . . 0.422 ' C ' ' HD2' ' H' ' 155' ' ' LYS . . . -92.25 49.57 2.7 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.389 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 155' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' H' ' 154' ' ' GLY . 0.9 OUTLIER -111.76 -176.84 3.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.751 0.31 . . . . 0.0 110.998 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 156' ' ' SER . . . . . . . . . . . . . 36.7 m -66.42 162.03 21.38 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.458 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 157' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' L' ' 48' ' ' PRO . 81.8 mt -76.73 149.85 36.32 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.39 102.61 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.054 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 159' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -59.03 110.61 1.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 160' ' ' ILE . . . . . . . . . . . . . 31.3 pt -90.19 -14.28 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 161' ' ' GLY . . . . . . . . . . . . . . . 151.31 -174.05 30.59 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.592 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 162' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -145.49 177.03 9.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 163' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -150.64 151.59 32.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 164' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' H' ' 166' ' ' TYR . 25.1 t-80 -132.04 115.53 15.38 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 165' ' ' PRO . . . . . 0.496 ' HB3' ' CE2' ' H' ' 141' ' ' PHE . 3.6 Cg_exo -73.61 -26.99 13.31 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.292 1.995 . . . . 0.0 114.313 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 166' ' ' TYR . . . . . 0.477 ' HB3' ' CE1' ' H' ' 164' ' ' HIS . 55.9 t80 -64.45 -57.54 8.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.389 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 167' ' ' SER . . . . . . . . . . . . . 84.4 p -99.36 1.1 44.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.039 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 168' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.09 42.5 28.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 169' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -106.97 137.72 44.51 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.832 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p -125.97 159.77 31.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.487 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.92 85.37 2.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.144 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 172' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -76.13 162.92 27.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.106 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 173' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -79.3 140.94 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -50.28 -25.07 3.35 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 175' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -88.28 -38.03 15.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.856 0.298 . . . . 0.0 111.734 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 176' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.7 24.07 11.76 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 177' ' ' LYS . . . . . 0.482 ' HD2' ' C ' ' H' ' 177' ' ' LYS . 2.4 tmmm? -76.7 107.99 9.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.814 0.34 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.64 -34.59 5.39 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.647 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 179' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -68.65 -37.95 80.07 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.675 0.238 . . . . 0.0 110.991 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 180' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.04 19.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 181' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -98.48 114.05 26.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.021 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 182' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' H' ' 192' ' ' TYR . 96.2 mt -88.87 103.48 16.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 183' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' H' ' 192' ' ' TYR . 39.6 m -78.34 149.7 33.38 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.557 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 184' ' ' VAL . . . . . . . . . . . . . 18.1 t -99.96 127.78 52.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.914 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 185' ' ' GLU . . . . . 0.55 ' HG3' ' CE2' ' H' ' 192' ' ' TYR . 16.4 mm-40 -137.49 62.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.416 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 186' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.03 -29.67 63.57 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 187' ' ' SER . . . . . . . . . . . . . 77.6 p -56.86 -41.79 78.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.33 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 188' ' ' SER . . . . . . . . . . . . . 78.1 p -109.18 9.49 26.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 189' ' ' SER . . . . . . . . . . . . . 57.8 m 50.76 42.28 27.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 111.428 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 190' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' H' ' 185' ' ' GLU . 86.4 m -129.18 133.35 47.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.062 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 191' ' ' VAL . . . . . 0.423 HG11 ' O ' ' H' ' 191' ' ' VAL . 7.2 p -103.51 120.1 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.084 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 192' ' ' TYR . . . . . 0.574 ' HB2' ' HB ' ' H' ' 183' ' ' THR . 23.9 m-85 -84.85 136.27 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 111.339 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 193' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' H' ' 132' ' ' MET . 48.7 tp -114.51 80.99 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.83 96.24 3.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.309 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.587 ' HB3' ' CD2' ' H' ' 198' ' ' LEU . 19.7 m-85 -84.47 111.7 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 196' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' H' ' 197' ' ' ARG . 57.3 m -97.7 158.76 15.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.225 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 197' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' H' ' 196' ' ' SER . 9.0 ptp180 38.44 55.51 1.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.205 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 198' ' ' LEU . . . . . 0.587 ' CD2' ' HB3' ' H' ' 195' ' ' PHE . 80.5 mt -71.08 114.78 9.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.238 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 199' ' ' THR . . . . . . . . . . . . . 59.6 p -79.49 161.7 25.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.663 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 200' ' ' SER . . . . . 0.407 ' HA ' ' CG1' ' H' ' 229' ' ' VAL . 83.9 p -52.94 -30.93 37.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.184 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -88.85 37.0 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 202' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -115.86 12.84 15.92 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 203' ' ' SER . . . . . . . . . . . . . 48.9 m -71.23 103.32 2.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 204' ' ' ALA . . . . . . . . . . . . . . . -147.37 169.2 19.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.094 0.474 . . . . 0.0 112.211 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 205' ' ' VAL . . . . . 0.423 HG11 ' CE2' ' H' ' 207' ' ' TYR . 13.7 t -103.44 102.34 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.543 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 206' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' H' ' 149' ' ' MET . 53.8 m-85 -78.27 149.63 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 0.0 111.405 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 207' ' ' TYR . . . . . 0.423 ' CE2' HG11 ' H' ' 205' ' ' VAL . 74.1 m-85 -145.14 118.19 8.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.878 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 208' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.09 74.26 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.21 179.068 50.335 151.906 80.708 104.341 2.033 104.41 124.945 175.945 1 1 . 1 . 001 nuclear orig full ' H' H ' 209' ' ' ALA . . . . . . . . . . . . . . . -92.19 149.97 21.17 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.61 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 210' ' ' ILE . . . . . 0.512 ' CD1' ' HB2' ' H' ' 220' ' ' TYR . 0.0 OUTLIER -129.85 169.75 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.175 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 211' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' H' ' 214' ' ' SER . 5.3 m80 -93.76 61.08 3.05 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 212' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -60.8 -50.63 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.581 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 213' ' ' GLY . . . . . . . . . . . . . . . -80.87 -80.68 0.85 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.235 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 214' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' H' ' 211' ' ' HIS . 87.7 p -88.14 155.36 19.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 215' ' ' ALA . . . . . . . . . . . . . . . -92.73 30.99 1.44 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.012 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 216' ' ' TYR . . . . . 0.459 ' CD2' ' HB1' ' L' ' 54' ' ' ALA . 66.2 m-85 -121.63 -51.73 2.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.565 0.221 . . . . 0.0 111.171 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 217' ' ' ALA . . . . . 0.466 ' HB1' ' HG ' ' L' ' 50' ' ' LEU . . . -126.24 175.78 7.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.276 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 218' ' ' MET . . . . . 0.427 ' SD ' ' CE1' ' H' ' 211' ' ' HIS . 4.3 mpp? -91.66 134.62 34.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 219' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.37 -43.99 5.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.074 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 220' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' H' ' 210' ' ' ILE . 0.9 OUTLIER -97.38 103.37 15.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 221' ' ' TRP . . . . . 0.431 ' CZ3' ' HE1' ' H' ' 149' ' ' MET . 38.0 m95 -94.29 174.21 7.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.107 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.15 167.92 48.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.562 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 223' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -86.96 33.48 0.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.34 118.16 0.11 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.918 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 225' ' ' THR . . . . . . . . . . . . . 49.7 p -147.89 133.3 18.59 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 226' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' H' ' 121' ' ' ALA . 47.0 m -139.86 135.6 33.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.788 0.327 . . . . 0.0 111.825 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 227' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.31 118.12 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 228' ' ' THR . . . . . . . . . . . . . 63.7 m -99.55 142.66 30.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 229' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' H' ' 200' ' ' SER . 24.9 t -99.16 132.8 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.304 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 230' ' ' SER . . . . . . . . . . . . . 73.3 p -63.49 -31.77 73.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.386 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 231' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.55 179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t70 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.507 0.194 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' L' ' 27' ' ' GLN . 3.8 mp -135.63 132.57 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.511 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' VAL . . . . . . . . . . . . . 45.6 t -91.42 122.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' LEU . . . . . 0.512 ' HB2' ' HA3' ' L' ' 103' ' ' GLY . 2.8 mm? -97.94 77.04 2.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.226 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' THR . . . . . . . . . . . . . 56.0 m -76.76 95.47 4.03 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.945 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -78.24 169.09 18.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 0.0 111.699 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' SER . . . . . 0.574 ' CB ' ' HD2' ' L' ' 8' ' ' PRO . 0.1 OUTLIER -76.06 -172.46 0.28 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.085 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' L' ' 7' ' ' SER . 37.2 Cg_exo -35.29 106.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.729 2.286 . . . . 0.0 113.02 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' L' ' 106' ' ' THR . . . -53.59 -42.47 67.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.201 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -118.01 131.01 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.737 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.404 ' CD2' ' C ' ' L' ' 11' ' ' LEU . 0.0 OUTLIER -159.14 159.68 34.69 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.321 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.93 131.72 55.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 0.0 111.396 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.82 122.11 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.437 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' L' ' 111' ' ' LYS . 80.4 p -70.28 161.19 30.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 111.317 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -64.28 117.56 7.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.47 -35.81 4.26 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.316 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -72.74 150.5 42.8 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.647 0.26 . . . . 0.0 110.562 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' ARG . . . . . 0.475 ' HB3' ' HA ' ' L' ' 80' ' ' HIS . 17.5 ptp180 -87.41 146.61 25.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.743 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.02 153.58 22.9 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.928 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -133.15 89.64 2.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 111.479 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' ILE . . . . . . . . . . . . . 40.0 mt -96.5 87.43 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' L' ' 76' ' ' THR . 77.9 p -86.96 118.01 26.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.949 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' L' ' 4' ' ' LEU . 42.8 t -101.15 106.36 17.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.159 178.851 176.075 134.035 69.697 103.983 2.027 103.924 158.488 51.456 2 2 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.37 133.87 34.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.698 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' ALA . . . . . 0.447 ' O ' ' HB ' ' L' ' 73' ' ' THR . . . -109.31 141.82 41.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' SER . . . . . . . . . . . . . 39.1 t -72.13 -33.77 68.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' GLN . . . . . 0.52 ' HB2' HG13 ' L' ' 2' ' ' ILE . 28.6 mm100 -119.91 157.06 29.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' SER . . . . . . . . . . . . . 75.0 p -67.96 119.4 12.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.681 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' VAL . . . . . . . . . . . . . 32.3 m -106.05 23.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.7 155.7 16.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.228 0.537 . . . . 0.0 111.959 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 31' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' P' ' 241' ' ' PRO . 3.2 t80 -124.26 -165.89 1.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.653 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -58.93 88.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 111.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.43 19.43 59.97 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.157 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -149.13 112.01 4.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.787 0.794 . . . . 0.0 111.02 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 35' ' ' SER . . . . . 0.508 ' HB3' ' CB ' ' L' ' 55' ' ' ALA . 2.6 t -79.48 141.35 36.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.184 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 36' ' ' TYR . . . . . 0.405 ' CZ ' ' HB2' ' P' ' 241' ' ' PRO . 18.9 m-85 -107.59 74.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.337 0.589 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 37' ' ' MET . . . . . . . . . . . . . 59.8 tpp -128.68 116.61 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.092 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 38' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -108.79 151.83 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.068 0.461 . . . . 0.0 111.786 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 39' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -126.04 131.37 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.737 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 40' ' ' TYR . . . . . 0.588 ' HB3' ' HB2' ' L' ' 48' ' ' PRO . 84.4 m-85 -117.37 150.87 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.809 0.338 . . . . 0.0 111.233 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 41' ' ' GLN . . . . . 0.511 ' HB2' ' CD1' ' L' ' 51' ' ' LEU . 59.9 tt0 -117.13 77.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 42' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -74.87 95.73 2.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.545 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 43' ' ' LYS . . . . . 0.508 ' HB3' ' HD2' ' L' ' 44' ' ' PRO . 57.2 mtpt -69.52 161.07 76.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.598 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 44' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' L' ' 43' ' ' LYS . 9.8 Cg_endo -53.21 99.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.635 2.223 . . . . 0.0 112.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.04 45.69 15.31 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.237 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 46' ' ' GLN . . . . . 0.47 ' HB3' ' HB2' ' L' ' 43' ' ' LYS . 10.7 tp-100 -155.61 133.99 7.18 Favored Pre-proline 0 C--O 1.234 0.279 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' OE1' ' L' ' 46' ' ' GLN . 7.8 Cg_endo -50.23 142.05 29.68 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.89 2.393 . . . . 0.0 112.738 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 48' ' ' PRO . . . . . 0.588 ' HB2' ' HB3' ' L' ' 40' ' ' TYR . 18.6 Cg_endo -59.69 109.71 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.078 2.518 . . . . 0.0 113.022 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.1 135.74 46.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 50' ' ' LEU . . . . . 0.466 ' HG ' ' HB1' ' H' ' 217' ' ' ALA . 1.1 tt -77.43 94.17 4.21 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 51' ' ' LEU . . . . . 0.511 ' CD1' ' HB2' ' L' ' 41' ' ' GLN . 87.8 mt -74.89 -63.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.272 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 52' ' ' ILE . . . . . 0.407 HD12 HG22 ' L' ' 52' ' ' ILE . 58.3 mt -123.34 145.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.885 0.374 . . . . 0.0 111.108 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 53' ' ' TYR . . . . . 0.436 ' HB2' ' HB2' ' H' ' 216' ' ' TYR . 12.7 p90 -134.46 161.76 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 54' ' ' ALA . . . . . 0.459 ' HB1' ' CD2' ' H' ' 216' ' ' TYR . . . 55.78 39.03 30.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 55' ' ' ALA . . . . . 0.508 ' CB ' ' HB3' ' L' ' 35' ' ' SER . . . 82.29 -65.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 56' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' L' ' 68' ' ' GLY . 81.7 p -138.25 18.48 2.77 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 57' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.41 100.84 13.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 110.522 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 58' ' ' LEU . . . . . 0.473 HD22 ' O ' ' L' ' 66' ' ' PHE . 12.3 mt -49.03 137.39 13.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.71 119.94 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.607 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 60' ' ' SER . . . . . . . . . . . . . 51.5 m -52.27 100.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.252 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.71 -44.41 0.41 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.465 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 62' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' L' ' 51' ' ' LEU . 38.4 pt -90.28 159.76 41.23 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 120.607 0.242 . . . . 0.0 110.999 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 63' ' ' PRO . . . . . 0.553 ' HB2' ' HG2' ' L' ' 65' ' ' ARG . 28.5 Cg_exo -61.45 167.94 8.87 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.613 2.209 . . . . 0.0 112.078 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.44 39.92 0.86 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 65' ' ' ARG . . . . . 0.553 ' HG2' ' HB2' ' L' ' 63' ' ' PRO . 47.3 ptt85 -115.3 -3.57 12.47 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 66' ' ' PHE . . . . . 0.473 ' O ' HD22 ' L' ' 58' ' ' LEU . 97.5 m-85 -100.2 79.8 2.2 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.913 0.387 . . . . 0.0 110.498 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 67' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' L' ' 78' ' ' ASN . 59.9 m -83.94 160.49 21.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 68' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' L' ' 56' ' ' SER . . . -141.71 110.2 0.63 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.317 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 69' ' ' SER . . . . . . . . . . . . . 88.7 p -109.8 114.14 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.784 0.292 . . . . 0.0 110.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 70' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' L' ' 75' ' ' PHE . . . -168.36 142.54 7.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -137.01 127.52 26.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.598 0.237 . . . . 0.0 110.661 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 72' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 68.65 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.114 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 73' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' L' ' 25' ' ' ALA . 76.4 p -124.21 -31.8 3.28 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 74' ' ' ASP . . . . . 0.43 ' O ' ' HA3' ' L' ' 70' ' ' GLY . 29.3 t70 -79.86 95.51 6.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.539 0.209 . . . . 0.0 111.157 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 75' ' ' PHE . . . . . 0.541 ' HA ' ' HA2' ' L' ' 70' ' ' GLY . 94.9 m-85 -110.31 159.56 17.32 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 76' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' L' ' 22' ' ' SER . 88.1 m -154.77 149.66 26.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.549 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 tp -111.25 100.1 8.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.289 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 78' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' L' ' 67' ' ' SER . 21.0 m120 -86.37 99.59 11.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.874 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -110.05 81.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 80' ' ' HIS . . . . . 0.702 ' HB3' ' HD3' ' L' ' 81' ' ' PRO . 1.4 t60 -55.42 -64.97 1.66 Allowed Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 81' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' L' ' 80' ' ' HIS . 89.3 Cg_endo -82.09 82.74 2.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.025 1.817 . . . . 0.0 112.203 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 82' ' ' VAL . . . . . . . . . . . . . 84.1 t -78.0 92.44 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 179.99 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.35 -26.14 67.62 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.15 -11.47 30.73 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 86' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -90.54 32.05 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.18 66.87 2.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.97 0.414 . . . . 0.0 110.43 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 88' ' ' ALA . . . . . 0.401 ' CB ' ' HA ' ' L' ' 43' ' ' LYS . . . -152.8 166.69 31.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.38 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 89' ' ' THR . . . . . . . . . . . . . 41.6 m -89.5 125.75 35.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 90' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' L' ' 40' ' ' TYR . 63.9 m-85 -97.43 131.4 44.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -122.19 149.25 43.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.776 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 92' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' L' ' 4' ' ' LEU . 9.5 p -116.82 107.27 14.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.285 179.033 51.456 158.488 69.697 103.924 2.027 103.983 134.035 176.075 2 2 . 1 . 001 nuclear orig full ' L' L ' 93' ' ' GLN . . . . . 0.501 ' HB2' ' CD2' ' L' ' 102' ' ' PHE . 56.0 tt0 -102.21 120.59 40.72 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.966 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 94' ' ' GLN . . . . . 0.516 ' HG2' ' HB ' ' L' ' 2' ' ' ILE . 4.5 pp0? -87.1 129.0 35.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.994 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 95' ' ' SER . . . . . . . . . . . . . 63.0 p -121.71 41.02 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 96' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -100.05 -48.22 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.61 150.76 50.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 111.169 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 98' ' ' ASP . . . . . 0.464 ' CG ' ' HA ' ' L' ' 99' ' ' PRO . 17.2 t70 -83.19 144.05 46.35 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 99' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' L' ' 98' ' ' ASP . 4.7 Cg_endo -87.32 149.97 36.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.922 -1.283 . . . . 0.0 112.1 -0.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -73.18 134.3 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.948 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 101' ' ' THR . . . . . . . . . . . . . 75.2 p -138.1 165.3 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.424 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 102' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' L' ' 93' ' ' GLN . 48.3 m-85 -106.68 173.03 6.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.656 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 103' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' L' ' 4' ' ' LEU . . . -92.11 169.03 31.69 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.295 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 104' ' ' SER . . . . . . . . . . . . . 75.6 p -52.64 -30.5 31.94 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.2 158.1 27.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 106' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' L' ' 9' ' ' ALA . 91.3 m -144.22 91.52 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.644 0.259 . . . . 0.0 111.161 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -67.47 93.8 0.37 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 108' ' ' LEU . . . . . . . . . . . . . 39.8 tp -80.49 109.83 15.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.859 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 109' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' L' ' 109' ' ' GLU . 0.3 OUTLIER -100.71 108.97 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.291 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.2 160.43 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.751 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 111' ' ' LYS . . . . . 0.497 ' HB3' ' HA ' ' L' ' 14' ' ' SER . 86.8 tttt -129.58 133.63 47.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 112' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.498 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 232' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.859 0.361 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' P' P ' 233' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' P' ' 248' ' ' ILE . 3.0 mmmm -133.12 142.25 48.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.607 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 234' ' ' SER . . . . . . . . . . . . . 59.5 m -142.92 136.52 28.67 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.65 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 235' ' ' ILE . . . . . . . . . . . . . 8.0 pt -131.69 145.64 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.183 0.516 . . . . 0.0 111.855 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 236' ' ' ARG . . . . . 0.587 ' CZ ' ' HD2' ' H' ' 145' ' ' PRO . 58.2 ttp85 -89.65 110.62 21.49 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 237' ' ' ILE . . . . . 0.494 HD11 HG22 ' P' ' 237' ' ' ILE . 0.2 OUTLIER -77.1 163.35 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 112.126 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 238' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -99.99 9.98 42.03 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.26 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 239' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -98.04 136.02 38.9 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 240' ' ' GLY . . . . . . . . . . . . . . . -69.79 169.75 44.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.818 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 241' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' L' ' 31' ' ' TYR . 5.7 Cg_exo -76.84 123.99 10.1 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.391 -1.504 . . . . 0.0 112.083 -0.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 242' ' ' GLY . . . . . . . . . . . . . . . 69.58 -176.28 32.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.014 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 243' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' P' ' 236' ' ' ARG . 1.2 mmt180 -111.44 82.45 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.28 176.91 7.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.264 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 245' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.16 137.83 49.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.431 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 246' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.24 125.32 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.728 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 247' ' ' THR . . . . . . . . . . . . . 49.4 m -89.35 98.61 11.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 248' ' ' ILE . . . . . 0.579 ' O ' ' HB2' ' P' ' 233' ' ' LYS . 35.2 pt -98.55 127.65 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.736 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 249' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 118.518 -1.157 . . . . 0.0 112.924 179.649 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 113' ' ' GLN . . . . . 0.416 ' O ' ' HA3' ' H' ' 138' ' ' GLY . 85.2 mt-30 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.368 0.128 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 114' ' ' VAL . . . . . 0.62 HG21 ' CE2' ' H' ' 212' ' ' TYR . 3.2 p -136.8 155.55 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 115' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -169.74 143.23 2.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 116' ' ' LEU . . . . . 0.775 HD13 ' O ' ' H' ' 208' ' ' CYS . 86.1 mt -106.23 89.83 3.18 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 117' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -86.1 88.45 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 118' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' H' ' 134' ' ' CYS . 11.1 pt20 -92.6 153.77 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -138.24 122.3 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.27 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 120' ' ' GLY . . . . . 0.505 ' HA3' ' HE2' ' H' ' 132' ' ' MET . . . -166.02 45.05 0.27 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.165 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 121' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' H' ' 226' ' ' SER . . . -100.78 76.14 1.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 122' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -122.47 151.57 41.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.67 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 123' ' ' LEU . . . . . 0.533 HD12 ' O ' ' H' ' 228' ' ' THR . 58.3 tp -92.68 79.16 4.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 124' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' H' ' 229' ' ' VAL . 27.6 m -64.26 146.46 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.346 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 125' ' ' LYS . . . . . 0.448 ' CG ' ' HD2' ' H' ' 126' ' ' PRO . 40.8 ttmt -107.34 144.57 29.46 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.747 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 126' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' H' ' 125' ' ' LYS . 88.4 Cg_exo -47.23 114.89 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.45 2.1 . . . . 0.0 112.589 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 26.02 18.38 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.988 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.19 178.79 4.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.856 0.328 . . . . 0.0 111.17 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 129' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' H' ' 195' ' ' PHE . 63.6 m -142.61 92.62 2.43 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.836 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 130' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.38 130.9 40.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.495 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 131' ' ' LYS . . . . . 0.544 ' HE2' ' CD2' ' H' ' 192' ' ' TYR . 81.2 tttt -101.92 103.3 13.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.808 0.337 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 132' ' ' MET . . . . . 0.544 ' HB2' ' HB3' ' H' ' 193' ' ' LEU . 86.0 mtp -75.25 170.27 16.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 133' ' ' SER . . . . . . . . . . . . . 73.7 p -148.69 112.82 5.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.84 0.353 . . . . 0.0 111.773 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 134' ' ' CYS . . . . . 0.468 ' HB2' ' CH2' ' H' ' 148' ' ' TRP . 42.2 t -103.06 98.21 8.19 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.93 175.945 124.945 80.708 104.41 2.033 104.341 151.906 50.335 2 2 . 1 . 001 nuclear build full ' H' H ' 135' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.81 149.2 34.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 136' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' H' ' 139' ' ' TYR . . . -128.59 90.71 3.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.656 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 137' ' ' SER . . . . . . . . . . . . . 61.6 p -84.89 143.87 28.75 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 138' ' ' GLY . . . . . 0.598 ' O ' HG23 ' H' ' 114' ' ' VAL . . . 65.45 25.02 71.2 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.098 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 139' ' ' TYR . . . . . 0.736 ' CG ' ' HB1' ' H' ' 136' ' ' ALA . 0.4 OUTLIER -109.94 155.96 21.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 140' ' ' THR . . . . . . . . . . . . . 47.3 m -90.35 -32.06 16.63 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 141' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' H' ' 165' ' ' PRO . 11.0 t80 72.12 -76.07 0.07 Allowed 'General case' 0 C--N 1.347 0.469 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.603 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 142' ' ' THR . . . . . . . . . . . . . 72.6 p -50.87 -34.01 26.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 143' ' ' THR . . . . . 0.461 HG23 ' HE1' ' P' ' 245' ' ' PHE . 50.7 m -85.74 -28.75 24.41 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 144' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -105.71 92.75 6.46 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 145' ' ' PRO . . . . . 0.58 ' HD2' ' CZ ' ' P' ' 236' ' ' ARG . 24.5 Cg_endo -63.09 143.17 89.92 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.166 1.911 . . . . 0.0 110.939 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 146' ' ' ILE . . . . . 0.548 ' HA ' HG22 ' H' ' 210' ' ' ILE . 58.1 mt -106.91 138.44 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 112.152 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 147' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -119.49 146.38 45.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.97 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 148' ' ' TRP . . . . . 0.536 ' CD2' HD22 ' H' ' 193' ' ' LEU . 93.3 m95 -111.83 136.21 51.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 111.381 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 149' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' H' ' 206' ' ' TYR . 3.6 mpp? -120.97 126.4 49.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.025 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 150' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -103.55 119.26 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 151' ' ' GLN . . . . . 0.489 ' HB2' HD23 ' H' ' 157' ' ' LEU . 59.9 tt0 -111.15 84.66 1.97 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 152' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' H' ' 155' ' ' LYS . 8.8 m120 -60.31 108.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 110.455 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 153' ' ' HIS . . . . . 0.44 ' HB2' ' HD3' ' H' ' 155' ' ' LYS . 88.7 m-70 60.42 -146.45 0.47 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.047 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 154' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' H' ' 155' ' ' LYS . . . -92.25 49.57 2.7 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.389 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 155' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' H' ' 153' ' ' HIS . 0.9 OUTLIER -111.76 -176.84 3.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.751 0.31 . . . . 0.0 110.998 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 156' ' ' SER . . . . . . . . . . . . . 36.7 m -66.42 162.03 21.38 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.458 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 157' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' L' ' 48' ' ' PRO . 81.8 mt -76.73 149.85 36.32 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.39 102.61 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.054 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 159' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -59.03 110.61 1.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 160' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' H' ' 148' ' ' TRP . 31.3 pt -90.19 -14.28 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 161' ' ' GLY . . . . . . . . . . . . . . . 151.31 -174.05 30.59 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.592 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 162' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -145.49 177.03 9.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 163' ' ' PHE . . . . . 0.502 ' CE2' HG22 ' H' ' 184' ' ' VAL . 13.9 t80 -150.64 151.59 32.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 164' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' H' ' 166' ' ' TYR . 25.1 t-80 -132.04 115.53 15.38 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 165' ' ' PRO . . . . . 0.525 ' HB3' ' CE2' ' H' ' 141' ' ' PHE . 3.6 Cg_exo -73.61 -26.99 13.31 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.292 1.995 . . . . 0.0 114.313 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 166' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' H' ' 164' ' ' HIS . 55.9 t80 -64.45 -57.54 8.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.389 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 167' ' ' SER . . . . . . . . . . . . . 84.4 p -99.36 1.1 44.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.039 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 168' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.09 42.5 28.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 169' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -106.97 137.72 44.51 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.832 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p -125.97 159.77 31.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.487 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 171' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -136.92 85.37 2.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.144 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 172' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -76.13 162.92 27.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.106 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 173' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -79.3 140.94 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -50.28 -25.07 3.35 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 175' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -88.28 -38.03 15.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.856 0.298 . . . . 0.0 111.734 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 176' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.7 24.07 11.76 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 177' ' ' LYS . . . . . 0.473 ' C ' ' HD2' ' H' ' 177' ' ' LYS . 2.4 tmmm? -76.7 107.99 9.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.814 0.34 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.64 -34.59 5.39 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.647 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 179' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -68.65 -37.95 80.07 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.675 0.238 . . . . 0.0 110.991 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 180' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.04 19.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 181' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -98.48 114.05 26.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.021 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 182' ' ' LEU . . . . . 0.659 HD21 HD13 ' H' ' 193' ' ' LEU . 96.2 mt -88.87 103.48 16.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 183' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' H' ' 192' ' ' TYR . 39.6 m -78.34 149.7 33.38 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.557 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 184' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' H' ' 163' ' ' PHE . 18.1 t -99.96 127.78 52.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.914 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 185' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' H' ' 192' ' ' TYR . 16.4 mm-40 -137.49 62.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.416 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 186' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.03 -29.67 63.57 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 187' ' ' SER . . . . . . . . . . . . . 77.6 p -56.86 -41.79 78.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.33 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 188' ' ' SER . . . . . . . . . . . . . 78.1 p -109.18 9.49 26.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 189' ' ' SER . . . . . . . . . . . . . 57.8 m 50.76 42.28 27.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 111.428 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 190' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' H' ' 185' ' ' GLU . 86.4 m -129.18 133.35 47.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.062 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 191' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.51 120.1 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.084 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 192' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' H' ' 183' ' ' THR . 23.9 m-85 -84.85 136.27 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 111.339 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 193' ' ' LEU . . . . . 0.659 HD13 HD21 ' H' ' 182' ' ' LEU . 48.7 tp -114.51 80.99 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.83 96.24 3.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.309 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.935 ' HB3' HD21 ' H' ' 198' ' ' LEU . 19.7 m-85 -84.47 111.7 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 196' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' H' ' 197' ' ' ARG . 57.3 m -97.7 158.76 15.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.225 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 197' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' H' ' 196' ' ' SER . 9.0 ptp180 38.44 55.51 1.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.205 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 198' ' ' LEU . . . . . 0.935 HD21 ' HB3' ' H' ' 195' ' ' PHE . 80.5 mt -71.08 114.78 9.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.238 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 199' ' ' THR . . . . . . . . . . . . . 59.6 p -79.49 161.7 25.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.663 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 200' ' ' SER . . . . . 0.88 ' HA ' HG11 ' H' ' 229' ' ' VAL . 83.9 p -52.94 -30.93 37.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.184 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -88.85 37.0 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 202' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -115.86 12.84 15.92 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 203' ' ' SER . . . . . . . . . . . . . 48.9 m -71.23 103.32 2.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 204' ' ' ALA . . . . . . . . . . . . . . . -147.37 169.2 19.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.094 0.474 . . . . 0.0 112.211 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 205' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' H' ' 207' ' ' TYR . 13.7 t -103.44 102.34 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.543 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 206' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' H' ' 149' ' ' MET . 53.8 m-85 -78.27 149.63 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 0.0 111.405 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 207' ' ' TYR . . . . . 0.462 ' CE2' HG12 ' H' ' 205' ' ' VAL . 74.1 m-85 -145.14 118.19 8.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.878 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 208' ' ' CYS . . . . . 0.775 ' O ' HD13 ' H' ' 116' ' ' LEU . 7.9 p -93.09 74.26 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.21 179.068 50.335 151.906 80.708 104.341 2.033 104.41 124.945 175.945 2 2 . 1 . 001 nuclear build full ' H' H ' 209' ' ' ALA . . . . . 0.542 ' HB1' ' HB3' ' H' ' 218' ' ' MET . . . -92.19 149.97 21.17 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.61 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 210' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' H' ' 212' ' ' TYR . 0.0 OUTLIER -129.85 169.75 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.175 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 211' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' H' ' 214' ' ' SER . 9.8 m-70 -93.76 61.08 3.05 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 212' ' ' TYR . . . . . 0.63 ' HB2' HD11 ' H' ' 210' ' ' ILE . 3.5 t80 -60.8 -50.63 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.581 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 213' ' ' GLY . . . . . . . . . . . . . . . -80.87 -80.68 0.85 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.235 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 214' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' H' ' 211' ' ' HIS . 87.7 p -88.14 155.36 19.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 215' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' P' ' 243' ' ' ARG . . . -92.73 30.99 1.44 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.012 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 216' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' L' ' 53' ' ' TYR . 66.2 m-85 -121.63 -51.73 2.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.565 0.221 . . . . 0.0 111.171 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 217' ' ' ALA . . . . . 0.894 ' HB2' ' CG ' ' L' ' 38' ' ' ASN . . . -126.24 175.78 7.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.276 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 218' ' ' MET . . . . . 0.542 ' HB3' ' HB1' ' H' ' 209' ' ' ALA . 4.3 mpp? -91.66 134.62 34.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 219' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.37 -43.99 5.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.074 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 220' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' H' ' 210' ' ' ILE . 0.9 OUTLIER -97.38 103.37 15.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 221' ' ' TRP . . . . . 0.436 ' CD2' ' HB2' ' H' ' 209' ' ' ALA . 38.0 m95 -94.29 174.21 7.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.107 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.15 167.92 48.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.562 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 223' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -86.96 33.48 0.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.34 118.16 0.11 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.918 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 225' ' ' THR . . . . . . . . . . . . . 49.7 p -147.89 133.3 18.59 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 226' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' H' ' 121' ' ' ALA . 47.0 m -139.86 135.6 33.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.788 0.327 . . . . 0.0 111.825 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 227' ' ' VAL . . . . . 0.425 ' O ' HG23 ' H' ' 227' ' ' VAL . 27.2 m -110.31 118.12 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 228' ' ' THR . . . . . 0.533 ' O ' HD12 ' H' ' 123' ' ' LEU . 63.7 m -99.55 142.66 30.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 229' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' H' ' 200' ' ' SER . 24.9 t -99.16 132.8 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.304 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 230' ' ' SER . . . . . . . . . . . . . 73.3 p -63.49 -31.77 73.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.386 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 231' ' ' SER . . . . . 0.545 ' H ' HG12 ' H' ' 229' ' ' VAL . 50.1 m . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.55 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 1' ' ' ASP . . . . . 0.612 ' C ' HD12 ' L' ' 2' ' ' ILE . 24.6 t70 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.507 0.194 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 2' ' ' ILE . . . . . 0.612 HD12 ' C ' ' L' ' 1' ' ' ASP . 3.8 mp -135.63 132.57 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.511 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 3' ' ' VAL . . . . . . . . . . . . . 45.6 t -91.42 122.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 4' ' ' LEU . . . . . 0.542 ' HB2' ' HA2' ' L' ' 103' ' ' GLY . 2.8 mm? -97.94 77.04 2.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.226 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 5' ' ' THR . . . . . . . . . . . . . 56.0 m -76.76 95.47 4.03 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.945 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -78.24 169.09 18.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 0.0 111.699 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 7' ' ' SER . . . . . 0.592 ' CB ' ' HD2' ' L' ' 8' ' ' PRO . 0.1 OUTLIER -76.06 -172.46 0.28 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.085 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 8' ' ' PRO . . . . . 0.592 ' HD2' ' CB ' ' L' ' 7' ' ' SER . 37.2 Cg_exo -35.29 106.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.729 2.286 . . . . 0.0 113.02 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 9' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' L' ' 106' ' ' THR . . . -53.59 -42.47 67.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.201 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -118.01 131.01 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.737 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.657 HD22 ' C ' ' L' ' 11' ' ' LEU . 0.0 OUTLIER -159.14 159.68 34.69 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.321 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.93 131.72 55.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 0.0 111.396 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 13' ' ' VAL . . . . . 0.597 ' CG1' HG11 ' L' ' 82' ' ' VAL . 7.2 p -132.82 122.11 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' L' ' 111' ' ' LYS . 80.4 p -70.28 161.19 30.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 111.317 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' L' ' 82' ' ' VAL . 84.4 mt -64.28 117.56 7.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.47 -35.81 4.26 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.316 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 17' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -72.74 150.5 42.8 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.647 0.26 . . . . 0.0 110.562 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 18' ' ' ARG . . . . . 0.511 ' HB3' ' HA ' ' L' ' 80' ' ' HIS . 17.5 ptp180 -87.41 146.61 25.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.743 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.02 153.58 22.9 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.928 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -133.15 89.64 2.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 111.479 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 21' ' ' ILE . . . . . . . . . . . . . 40.0 mt -96.5 87.43 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 22' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' L' ' 76' ' ' THR . 77.9 p -86.96 118.01 26.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.949 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 23' ' ' CYS . . . . . 0.425 ' HB2' ' CH2' ' L' ' 39' ' ' TRP . 42.8 t -101.15 106.36 17.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.159 178.851 176.075 134.035 69.697 103.983 2.027 103.924 158.488 51.456 2 2 . 1 . 001 nuclear build full ' L' L ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.37 133.87 34.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.698 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' L' ' 73' ' ' THR . . . -109.31 141.82 41.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 26' ' ' SER . . . . . . . . . . . . . 39.1 t -72.13 -33.77 68.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 27' ' ' GLN . . . . . 0.548 ' HB2' HG13 ' L' ' 2' ' ' ILE . 28.6 mm100 -119.91 157.06 29.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 28' ' ' SER . . . . . . . . . . . . . 75.0 p -67.96 119.4 12.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.681 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 29' ' ' VAL . . . . . . . . . . . . . 32.3 m -106.05 23.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.7 155.7 16.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.228 0.537 . . . . 0.0 111.959 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 31' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' P' ' 241' ' ' PRO . 3.2 t80 -124.26 -165.89 1.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.653 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -58.93 88.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 111.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.43 19.43 59.97 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.157 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -149.13 112.01 4.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.787 0.794 . . . . 0.0 111.02 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 35' ' ' SER . . . . . 0.674 ' HB3' ' HB2' ' L' ' 55' ' ' ALA . 2.6 t -79.48 141.35 36.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.184 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 36' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' P' ' 241' ' ' PRO . 18.9 m-85 -107.59 74.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.337 0.589 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 37' ' ' MET . . . . . . . . . . . . . 59.8 tpp -128.68 116.61 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.092 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 38' ' ' ASN . . . . . 0.894 ' CG ' ' HB2' ' H' ' 217' ' ' ALA . 47.7 m-80 -108.79 151.83 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.068 0.461 . . . . 0.0 111.786 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 39' ' ' TRP . . . . . 0.425 ' CH2' ' HB2' ' L' ' 23' ' ' CYS . 84.7 m95 -126.04 131.37 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.737 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 40' ' ' TYR . . . . . 0.605 ' HB3' ' HB2' ' L' ' 48' ' ' PRO . 84.4 m-85 -117.37 150.87 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.809 0.338 . . . . 0.0 111.233 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 41' ' ' GLN . . . . . 0.831 ' HB2' HD11 ' L' ' 51' ' ' LEU . 59.9 tt0 -117.13 77.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 42' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -74.87 95.73 2.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.545 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 43' ' ' LYS . . . . . 0.512 ' HB3' ' HD2' ' L' ' 44' ' ' PRO . 57.2 mtpt -69.52 161.07 76.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.598 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 44' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' L' ' 43' ' ' LYS . 9.8 Cg_endo -53.21 99.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.635 2.223 . . . . 0.0 112.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.04 45.69 15.31 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.237 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 46' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' L' ' 43' ' ' LYS . 10.7 tp-100 -155.61 133.99 7.18 Favored Pre-proline 0 C--O 1.234 0.279 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 47' ' ' PRO . . . . . 0.427 ' HD2' ' OE1' ' L' ' 46' ' ' GLN . 7.8 Cg_endo -50.23 142.05 29.68 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.89 2.393 . . . . 0.0 112.738 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 48' ' ' PRO . . . . . 0.663 ' HG3' HD11 ' H' ' 157' ' ' LEU . 18.6 Cg_endo -59.69 109.71 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.078 2.518 . . . . 0.0 113.022 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.1 135.74 46.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 50' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' H' ' 217' ' ' ALA . 1.1 tt -77.43 94.17 4.21 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 51' ' ' LEU . . . . . 0.831 HD11 ' HB2' ' L' ' 41' ' ' GLN . 87.8 mt -74.89 -63.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.272 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 52' ' ' ILE . . . . . 0.463 HD11 ' O ' ' L' ' 66' ' ' PHE . 58.3 mt -123.34 145.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.885 0.374 . . . . 0.0 111.108 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 53' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' H' ' 216' ' ' TYR . 12.7 p90 -134.46 161.76 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 54' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' L' ' 55' ' ' ALA . . . 55.78 39.03 30.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 55' ' ' ALA . . . . . 0.674 ' HB2' ' HB3' ' L' ' 35' ' ' SER . . . 82.29 -65.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 56' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' L' ' 68' ' ' GLY . 81.7 p -138.25 18.48 2.77 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 57' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.41 100.84 13.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 110.522 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.03 137.39 13.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.71 119.94 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.607 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 60' ' ' SER . . . . . . . . . . . . . 51.5 m -52.27 100.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.252 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.71 -44.41 0.41 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.465 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 62' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' L' ' 51' ' ' LEU . 38.4 pt -90.28 159.76 41.23 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 120.607 0.242 . . . . 0.0 110.999 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 63' ' ' PRO . . . . . 0.571 ' HB2' ' HG2' ' L' ' 65' ' ' ARG . 28.5 Cg_exo -61.45 167.94 8.87 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.613 2.209 . . . . 0.0 112.078 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.44 39.92 0.86 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 65' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' L' ' 63' ' ' PRO . 47.3 ptt85 -115.3 -3.57 12.47 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 66' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' L' ' 62' ' ' ILE . 97.5 m-85 -100.2 79.8 2.2 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.913 0.387 . . . . 0.0 110.498 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 67' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' L' ' 78' ' ' ASN . 59.9 m -83.94 160.49 21.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 68' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' L' ' 56' ' ' SER . . . -141.71 110.2 0.63 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.317 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 69' ' ' SER . . . . . . . . . . . . . 88.7 p -109.8 114.14 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.784 0.292 . . . . 0.0 110.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 70' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' L' ' 75' ' ' PHE . . . -168.36 142.54 7.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -137.01 127.52 26.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.598 0.237 . . . . 0.0 110.661 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 72' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 68.65 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.114 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 73' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' L' ' 25' ' ' ALA . 76.4 p -124.21 -31.8 3.28 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 74' ' ' ASP . . . . . 0.447 ' O ' ' HA2' ' L' ' 70' ' ' GLY . 29.3 t70 -79.86 95.51 6.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.539 0.209 . . . . 0.0 111.157 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 75' ' ' PHE . . . . . 0.573 ' HA ' ' HA3' ' L' ' 70' ' ' GLY . 94.9 m-85 -110.31 159.56 17.32 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 76' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' L' ' 22' ' ' SER . 88.1 m -154.77 149.66 26.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.549 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 tp -111.25 100.1 8.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.289 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 78' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' L' ' 67' ' ' SER . 21.0 m120 -86.37 99.59 11.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.874 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -110.05 81.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 80' ' ' HIS . . . . . 0.734 ' HB3' ' HD3' ' L' ' 81' ' ' PRO . 1.4 t60 -55.42 -64.97 1.66 Allowed Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 81' ' ' PRO . . . . . 0.734 ' HD3' ' HB3' ' L' ' 80' ' ' HIS . 89.3 Cg_endo -82.09 82.74 2.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.025 1.817 . . . . 0.0 112.203 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 82' ' ' VAL . . . . . 0.597 HG11 ' CG1' ' L' ' 13' ' ' VAL . 84.1 t -78.0 92.44 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 179.99 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.35 -26.14 67.62 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.15 -11.47 30.73 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 86' ' ' ASP . . . . . 0.516 ' HB3' HD23 ' L' ' 108' ' ' LEU . 53.2 m-20 -90.54 32.05 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.18 66.87 2.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.97 0.414 . . . . 0.0 110.43 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 88' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' L' ' 43' ' ' LYS . . . -152.8 166.69 31.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.38 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 89' ' ' THR . . . . . . . . . . . . . 41.6 m -89.5 125.75 35.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 90' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' L' ' 40' ' ' TYR . 63.9 m-85 -97.43 131.4 44.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -122.19 149.25 43.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.776 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 92' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' L' ' 4' ' ' LEU . 9.5 p -116.82 107.27 14.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.285 179.033 51.456 158.488 69.697 103.924 2.027 103.983 134.035 176.075 2 2 . 1 . 001 nuclear build full ' L' L ' 93' ' ' GLN . . . . . 0.505 ' HB2' ' CD2' ' L' ' 102' ' ' PHE . 56.0 tt0 -102.21 120.59 40.72 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.966 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 94' ' ' GLN . . . . . 0.514 ' HG2' ' HB ' ' L' ' 2' ' ' ILE . 4.5 pp0? -87.1 129.0 35.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.994 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 95' ' ' SER . . . . . . . . . . . . . 63.0 p -121.71 41.02 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 96' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -100.05 -48.22 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 97' ' ' GLU . . . . . 0.563 ' HB3' HD11 ' L' ' 2' ' ' ILE . 35.4 tt0 -129.61 150.76 50.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 111.169 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 98' ' ' ASP . . . . . 0.438 ' CG ' ' HA ' ' L' ' 99' ' ' PRO . 17.2 t70 -83.19 144.05 46.35 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' L' ' 98' ' ' ASP . 4.7 Cg_endo -87.32 149.97 36.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.922 -1.283 . . . . 0.0 112.1 -0.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -73.18 134.3 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.948 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 101' ' ' THR . . . . . . . . . . . . . 75.2 p -138.1 165.3 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.424 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' L' ' 93' ' ' GLN . 48.3 m-85 -106.68 173.03 6.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.656 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 103' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' L' ' 4' ' ' LEU . . . -92.11 169.03 31.69 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.295 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 104' ' ' SER . . . . . . . . . . . . . 75.6 p -52.64 -30.5 31.94 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.2 158.1 27.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 106' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' L' ' 9' ' ' ALA . 91.3 m -144.22 91.52 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.644 0.259 . . . . 0.0 111.161 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -67.47 93.8 0.37 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 108' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' L' ' 86' ' ' ASP . 39.8 tp -80.49 109.83 15.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.859 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 109' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' L' ' 109' ' ' GLU . 0.3 OUTLIER -100.71 108.97 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.291 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 110' ' ' ILE . . . . . 0.586 ' C ' HD12 ' L' ' 110' ' ' ILE . 2.3 pp -68.2 160.43 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.751 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 111' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' L' ' 14' ' ' SER . 86.8 tttt -129.58 133.63 47.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 112' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' L' ' 112' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.498 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 232' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.859 0.361 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 233' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' P' ' 248' ' ' ILE . 3.0 mmmm -133.12 142.25 48.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.607 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 234' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' P' ' 246' ' ' VAL . 59.5 m -142.92 136.52 28.67 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.65 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 235' ' ' ILE . . . . . . . . . . . . . 8.0 pt -131.69 145.64 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.183 0.516 . . . . 0.0 111.855 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 236' ' ' ARG . . . . . 0.58 ' CZ ' ' HD2' ' H' ' 145' ' ' PRO . 58.2 ttp85 -89.65 110.62 21.49 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 237' ' ' ILE . . . . . 0.496 ' H ' HD13 ' P' ' 237' ' ' ILE . 0.2 OUTLIER -77.1 163.35 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 112.126 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 238' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -99.99 9.98 42.03 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.26 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 239' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -98.04 136.02 38.9 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 240' ' ' GLY . . . . . . . . . . . . . . . -69.79 169.75 44.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.818 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 241' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' L' ' 31' ' ' TYR . 5.7 Cg_exo -76.84 123.99 10.1 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.391 -1.504 . . . . 0.0 112.083 -0.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 242' ' ' GLY . . . . . . . . . . . . . . . 69.58 -176.28 32.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.014 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 243' ' ' ARG . . . . . 0.479 ' O ' ' HB1' ' H' ' 215' ' ' ALA . 1.2 mmt180 -111.44 82.45 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 244' ' ' ALA . . . . . 0.443 ' O ' HD13 ' P' ' 237' ' ' ILE . . . -76.28 176.91 7.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.264 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 245' ' ' PHE . . . . . 0.461 ' HE1' HG23 ' H' ' 143' ' ' THR . 2.0 m-85 -112.16 137.83 49.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.431 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 246' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' P' ' 234' ' ' SER . 27.4 m -124.24 125.32 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.728 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 247' ' ' THR . . . . . . . . . . . . . 49.4 m -89.35 98.61 11.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 248' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' P' ' 233' ' ' LYS . 35.2 pt -98.55 127.65 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.736 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 249' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 118.518 -1.157 . . . . 0.0 112.924 179.649 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 113' ' ' GLN . . . . . 0.416 ' O ' ' HA3' ' H' ' 138' ' ' GLY . 85.2 mt-30 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.368 0.128 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 114' ' ' VAL . . . . . 0.62 HG21 ' CE2' ' H' ' 212' ' ' TYR . 3.2 p -136.8 155.55 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 115' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -169.74 143.23 2.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.572 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 116' ' ' LEU . . . . . 0.775 HD13 ' O ' ' H' ' 208' ' ' CYS . 86.1 mt -106.23 89.83 3.18 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 117' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -86.1 88.45 7.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 118' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' H' ' 134' ' ' CYS . 11.1 pt20 -92.6 153.77 18.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.051 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -138.24 122.3 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.27 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 120' ' ' GLY . . . . . 0.505 ' HA3' ' HE2' ' H' ' 132' ' ' MET . . . -166.02 45.05 0.27 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.165 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 121' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' H' ' 226' ' ' SER . . . -100.78 76.14 1.77 Allowed 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 122' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -122.47 151.57 41.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.67 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 123' ' ' LEU . . . . . 0.533 HD12 ' O ' ' H' ' 228' ' ' THR . 58.3 tp -92.68 79.16 4.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.373 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 124' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' H' ' 229' ' ' VAL . 27.6 m -64.26 146.46 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.346 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 125' ' ' LYS . . . . . 0.448 ' CG ' ' HD2' ' H' ' 126' ' ' PRO . 40.8 ttmt -107.34 144.57 29.46 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.747 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 126' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' H' ' 125' ' ' LYS . 88.4 Cg_exo -47.23 114.89 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.45 2.1 . . . . 0.0 112.589 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 26.02 18.38 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.988 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.19 178.79 4.46 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.856 0.328 . . . . 0.0 111.17 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 129' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' H' ' 195' ' ' PHE . 63.6 m -142.61 92.62 2.43 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.836 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 130' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.38 130.9 40.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.495 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 131' ' ' LYS . . . . . 0.544 ' HE2' ' CD2' ' H' ' 192' ' ' TYR . 81.2 tttt -101.92 103.3 13.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.808 0.337 . . . . 0.0 110.958 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 132' ' ' MET . . . . . 0.544 ' HB2' ' HB3' ' H' ' 193' ' ' LEU . 86.0 mtp -75.25 170.27 16.39 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.841 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 133' ' ' SER . . . . . . . . . . . . . 73.7 p -148.69 112.82 5.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.84 0.353 . . . . 0.0 111.773 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 134' ' ' CYS . . . . . 0.468 ' HB2' ' CH2' ' H' ' 148' ' ' TRP . 42.2 t -103.06 98.21 8.19 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.93 175.945 124.945 80.708 104.41 2.033 104.341 151.906 50.335 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 135' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -77.81 149.2 34.44 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.847 0.356 . . . . 0.0 110.786 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 136' ' ' ALA . . . . . 0.736 ' HB1' ' CG ' ' H' ' 139' ' ' TYR . . . -128.59 90.71 3.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.656 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 137' ' ' SER . . . . . . . . . . . . . 61.6 p -84.89 143.87 28.75 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 138' ' ' GLY . . . . . 0.598 ' O ' HG23 ' H' ' 114' ' ' VAL . . . 65.45 25.02 71.2 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 119.982 -1.104 . . . . 0.0 111.098 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 139' ' ' TYR . . . . . 0.736 ' CG ' ' HB1' ' H' ' 136' ' ' ALA . 0.4 OUTLIER -109.94 155.96 21.07 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 140' ' ' THR . . . . . . . . . . . . . 47.3 m -90.35 -32.06 16.63 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 141' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' H' ' 165' ' ' PRO . 11.0 t80 72.12 -76.07 0.07 Allowed 'General case' 0 C--N 1.347 0.469 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.603 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 142' ' ' THR . . . . . . . . . . . . . 72.6 p -50.87 -34.01 26.34 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 143' ' ' THR . . . . . 0.461 HG23 ' HE1' ' P' ' 245' ' ' PHE . 50.7 m -85.74 -28.75 24.41 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 144' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -105.71 92.75 6.46 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 145' ' ' PRO . . . . . 0.58 ' HD2' ' CZ ' ' P' ' 236' ' ' ARG . 24.5 Cg_endo -63.09 143.17 89.92 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.166 1.911 . . . . 0.0 110.939 178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 146' ' ' ILE . . . . . 0.548 ' HA ' HG22 ' H' ' 210' ' ' ILE . 58.1 mt -106.91 138.44 32.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 112.152 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 147' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -119.49 146.38 45.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.97 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 148' ' ' TRP . . . . . 0.536 ' CD2' HD22 ' H' ' 193' ' ' LEU . 93.3 m95 -111.83 136.21 51.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.793 0.33 . . . . 0.0 111.381 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 149' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' H' ' 206' ' ' TYR . 3.6 mpp? -120.97 126.4 49.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.025 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 150' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -103.55 119.26 38.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 151' ' ' GLN . . . . . 0.489 ' HB2' HD23 ' H' ' 157' ' ' LEU . 59.9 tt0 -111.15 84.66 1.97 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 152' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' H' ' 155' ' ' LYS . 8.8 m120 -60.31 108.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.591 0.234 . . . . 0.0 110.455 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 153' ' ' HIS . . . . . 0.44 ' HB2' ' HD3' ' H' ' 155' ' ' LYS . 88.7 m-70 60.42 -146.45 0.47 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.047 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 154' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' H' ' 155' ' ' LYS . . . -92.25 49.57 2.7 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.389 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 155' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' H' ' 153' ' ' HIS . 0.9 OUTLIER -111.76 -176.84 3.03 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.751 0.31 . . . . 0.0 110.998 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 156' ' ' SER . . . . . . . . . . . . . 36.7 m -66.42 162.03 21.38 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.458 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 157' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' L' ' 48' ' ' PRO . 81.8 mt -76.73 149.85 36.32 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.651 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -131.39 102.61 6.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.054 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 159' ' ' TRP . . . . . . . . . . . . . 70.7 t90 -59.03 110.61 1.07 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 160' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' H' ' 148' ' ' TRP . 31.3 pt -90.19 -14.28 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 161' ' ' GLY . . . . . . . . . . . . . . . 151.31 -174.05 30.59 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.592 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 162' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -145.49 177.03 9.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.776 0.322 . . . . 0.0 111.119 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 163' ' ' PHE . . . . . 0.502 ' CE2' HG22 ' H' ' 184' ' ' VAL . 13.9 t80 -150.64 151.59 32.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 164' ' ' HIS . . . . . 0.506 ' CE1' ' HB3' ' H' ' 166' ' ' TYR . 25.1 t-80 -132.04 115.53 15.38 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 165' ' ' PRO . . . . . 0.525 ' HB3' ' CE2' ' H' ' 141' ' ' PHE . 3.6 Cg_exo -73.61 -26.99 13.31 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.292 1.995 . . . . 0.0 114.313 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 166' ' ' TYR . . . . . 0.506 ' HB3' ' CE1' ' H' ' 164' ' ' HIS . 55.9 t80 -64.45 -57.54 8.96 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.389 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 167' ' ' SER . . . . . . . . . . . . . 84.4 p -99.36 1.1 44.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.039 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 168' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 56.09 42.5 28.29 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.953 0.406 . . . . 0.0 110.528 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 169' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -106.97 137.72 44.51 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.832 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p -125.97 159.77 31.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.487 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.92 85.37 2.13 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.144 177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 172' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -76.13 162.92 27.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.106 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 173' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -79.3 140.94 37.42 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 174' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -50.28 -25.07 3.35 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 175' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -88.28 -38.03 15.53 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.856 0.298 . . . . 0.0 111.734 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 176' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -103.7 24.07 11.76 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 177' ' ' LYS . . . . . 0.473 ' C ' ' HD2' ' H' ' 177' ' ' LYS . 2.4 tmmm? -76.7 107.99 9.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.814 0.34 . . . . 0.0 110.219 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 178' ' ' GLY . . . . . . . . . . . . . . . 109.64 -34.59 5.39 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.647 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 179' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -68.65 -37.95 80.07 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.675 0.238 . . . . 0.0 110.991 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 180' ' ' ALA . . . . . . . . . . . . . . . -105.35 108.04 19.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.725 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 181' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -98.48 114.05 26.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.021 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 182' ' ' LEU . . . . . 0.659 HD21 HD13 ' H' ' 193' ' ' LEU . 96.2 mt -88.87 103.48 16.04 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . 0.589 ' HB ' ' HB2' ' H' ' 192' ' ' TYR . 39.6 m -78.34 149.7 33.38 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.557 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 184' ' ' VAL . . . . . 0.502 HG22 ' CE2' ' H' ' 163' ' ' PHE . 18.1 t -99.96 127.78 52.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.914 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 185' ' ' GLU . . . . . 0.578 ' HG3' ' CE2' ' H' ' 192' ' ' TYR . 16.4 mm-40 -137.49 62.14 1.59 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.416 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 186' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.03 -29.67 63.57 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 187' ' ' SER . . . . . . . . . . . . . 77.6 p -56.86 -41.79 78.57 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.33 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 188' ' ' SER . . . . . . . . . . . . . 78.1 p -109.18 9.49 26.04 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 189' ' ' SER . . . . . . . . . . . . . 57.8 m 50.76 42.28 27.35 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.756 0.312 . . . . 0.0 111.428 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 190' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' H' ' 185' ' ' GLU . 86.4 m -129.18 133.35 47.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.062 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 191' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.51 120.1 53.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.084 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 192' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' H' ' 183' ' ' THR . 23.9 m-85 -84.85 136.27 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 111.339 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 193' ' ' LEU . . . . . 0.659 HD13 HD21 ' H' ' 182' ' ' LEU . 48.7 tp -114.51 80.99 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.83 96.24 3.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.309 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.935 ' HB3' HD21 ' H' ' 198' ' ' LEU . 19.7 m-85 -84.47 111.7 19.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 196' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' H' ' 197' ' ' ARG . 57.3 m -97.7 158.76 15.33 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.225 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 197' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' H' ' 196' ' ' SER . 9.0 ptp180 38.44 55.51 1.83 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.205 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 198' ' ' LEU . . . . . 0.935 HD21 ' HB3' ' H' ' 195' ' ' PHE . 80.5 mt -71.08 114.78 9.48 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.238 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 199' ' ' THR . . . . . . . . . . . . . 59.6 p -79.49 161.7 25.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.663 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 200' ' ' SER . . . . . 0.88 ' HA ' HG11 ' H' ' 229' ' ' VAL . 83.9 p -52.94 -30.93 37.5 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.184 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 201' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -88.85 37.0 0.82 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 202' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -115.86 12.84 15.92 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 203' ' ' SER . . . . . . . . . . . . . 48.9 m -71.23 103.32 2.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 204' ' ' ALA . . . . . . . . . . . . . . . -147.37 169.2 19.98 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.094 0.474 . . . . 0.0 112.211 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 205' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' H' ' 207' ' ' TYR . 13.7 t -103.44 102.34 13.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.543 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 206' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' H' ' 149' ' ' MET . 53.8 m-85 -78.27 149.63 33.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 0.0 111.405 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 207' ' ' TYR . . . . . 0.462 ' CE2' HG12 ' H' ' 205' ' ' VAL . 74.1 m-85 -145.14 118.19 8.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.878 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 208' ' ' CYS . . . . . 0.775 ' O ' HD13 ' H' ' 116' ' ' LEU . 7.9 p -93.09 74.26 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.21 179.068 50.335 151.906 80.708 104.341 2.033 104.41 124.945 175.945 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 209' ' ' ALA . . . . . 0.542 ' HB1' ' HB3' ' H' ' 218' ' ' MET . . . -92.19 149.97 21.17 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.61 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 210' ' ' ILE . . . . . 0.63 HD11 ' HB2' ' H' ' 212' ' ' TYR . 0.0 OUTLIER -129.85 169.75 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.175 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 211' ' ' HIS . . . . . 0.521 ' HB3' ' O ' ' H' ' 214' ' ' SER . 5.3 m80 -93.76 61.08 3.05 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 212' ' ' TYR . . . . . 0.63 ' HB2' HD11 ' H' ' 210' ' ' ILE . 3.5 t80 -60.8 -50.63 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.581 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 213' ' ' GLY . . . . . . . . . . . . . . . -80.87 -80.68 0.85 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.235 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 214' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' H' ' 211' ' ' HIS . 87.7 p -88.14 155.36 19.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.268 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 215' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' P' ' 243' ' ' ARG . . . -92.73 30.99 1.44 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.012 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 216' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' L' ' 53' ' ' TYR . 66.2 m-85 -121.63 -51.73 2.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.565 0.221 . . . . 0.0 111.171 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 217' ' ' ALA . . . . . 0.894 ' HB2' ' CG ' ' L' ' 38' ' ' ASN . . . -126.24 175.78 7.55 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.831 0.348 . . . . 0.0 111.276 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 218' ' ' MET . . . . . 0.542 ' HB3' ' HB1' ' H' ' 209' ' ' ALA . 4.3 mpp? -91.66 134.62 34.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.767 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 219' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -104.37 -43.99 5.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.074 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 220' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' H' ' 210' ' ' ILE . 0.9 OUTLIER -97.38 103.37 15.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.404 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 221' ' ' TRP . . . . . 0.436 ' CD2' ' HB2' ' H' ' 209' ' ' ALA . 38.0 m95 -94.29 174.21 7.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.107 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.15 167.92 48.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.562 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 223' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -86.96 33.48 0.66 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 224' ' ' GLY . . . . . . . . . . . . . . . 75.34 118.16 0.11 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.918 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 225' ' ' THR . . . . . . . . . . . . . 49.7 p -147.89 133.3 18.59 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 226' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' H' ' 121' ' ' ALA . 47.0 m -139.86 135.6 33.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.788 0.327 . . . . 0.0 111.825 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 227' ' ' VAL . . . . . 0.425 ' O ' HG23 ' H' ' 227' ' ' VAL . 27.2 m -110.31 118.12 56.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.335 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 228' ' ' THR . . . . . 0.533 ' O ' HD12 ' H' ' 123' ' ' LEU . 63.7 m -99.55 142.66 30.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 229' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' H' ' 200' ' ' SER . 24.9 t -99.16 132.8 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.304 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 230' ' ' SER . . . . . . . . . . . . . 73.3 p -63.49 -31.77 73.02 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.386 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 231' ' ' SER . . . . . 0.545 ' H ' HG12 ' H' ' 229' ' ' VAL . 50.1 m . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.55 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' ASP . . . . . 0.612 ' C ' HD12 ' L' ' 2' ' ' ILE . 24.6 t70 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.507 0.194 . . . . 0.0 110.726 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' ILE . . . . . 0.612 HD12 ' C ' ' L' ' 1' ' ' ASP . 3.8 mp -135.63 132.57 51.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.511 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' VAL . . . . . . . . . . . . . 45.6 t -91.42 122.86 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' LEU . . . . . 0.542 ' HB2' ' HA2' ' L' ' 103' ' ' GLY . 2.8 mm? -97.94 77.04 2.45 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.006 0.432 . . . . 0.0 111.226 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' THR . . . . . . . . . . . . . 56.0 m -76.76 95.47 4.03 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.945 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -78.24 169.09 18.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.05 0.452 . . . . 0.0 111.699 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' SER . . . . . 0.592 ' CB ' ' HD2' ' L' ' 8' ' ' PRO . 0.1 OUTLIER -76.06 -172.46 0.28 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.085 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' PRO . . . . . 0.592 ' HD2' ' CB ' ' L' ' 7' ' ' SER . 37.2 Cg_exo -35.29 106.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.729 2.286 . . . . 0.0 113.02 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' L' ' 106' ' ' THR . . . -53.59 -42.47 67.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.201 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' SER . . . . . . . . . . . . . 78.0 p -118.01 131.01 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.737 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.657 HD22 ' C ' ' L' ' 11' ' ' LEU . 0.0 OUTLIER -159.14 159.68 34.69 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.321 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.93 131.72 55.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.701 0.286 . . . . 0.0 111.396 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' VAL . . . . . 0.597 ' CG1' HG11 ' L' ' 82' ' ' VAL . 7.2 p -132.82 122.11 45.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.437 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' L' ' 111' ' ' LYS . 80.4 p -70.28 161.19 30.82 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.87 0.367 . . . . 0.0 111.317 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' L' ' 82' ' ' VAL . 84.4 mt -64.28 117.56 7.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.552 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.47 -35.81 4.26 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.316 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -72.74 150.5 42.8 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.647 0.26 . . . . 0.0 110.562 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' ARG . . . . . 0.511 ' HB3' ' HA ' ' L' ' 80' ' ' HIS . 17.5 ptp180 -87.41 146.61 25.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.743 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.02 153.58 22.9 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.928 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -133.15 89.64 2.64 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 111.479 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' ILE . . . . . . . . . . . . . 40.0 mt -96.5 87.43 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' L' ' 76' ' ' THR . 77.9 p -86.96 118.01 26.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.949 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' CYS . . . . . 0.425 ' HB2' ' CH2' ' L' ' 39' ' ' TRP . 42.8 t -101.15 106.36 17.59 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.159 178.851 176.075 134.035 69.697 103.983 2.027 103.924 158.488 51.456 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.37 133.87 34.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.698 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HB ' ' L' ' 73' ' ' THR . . . -109.31 141.82 41.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.786 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' SER . . . . . . . . . . . . . 39.1 t -72.13 -33.77 68.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' GLN . . . . . 0.548 ' HB2' HG13 ' L' ' 2' ' ' ILE . 28.6 mm100 -119.91 157.06 29.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' SER . . . . . . . . . . . . . 75.0 p -67.96 119.4 12.55 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.681 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' VAL . . . . . . . . . . . . . 32.3 m -106.05 23.43 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.179 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.7 155.7 16.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.228 0.537 . . . . 0.0 111.959 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 31' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' P' ' 241' ' ' PRO . 3.2 t80 -124.26 -165.89 1.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.653 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 32' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -58.93 88.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.016 0.436 . . . . 0.0 111.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 33' ' ' GLY . . . . . . . . . . . . . . . 62.43 19.43 59.97 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.657 -0.702 . . . . 0.0 114.157 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 34' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -149.13 112.01 4.84 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.787 0.794 . . . . 0.0 111.02 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 35' ' ' SER . . . . . 0.674 ' HB3' ' HB2' ' L' ' 55' ' ' ALA . 2.6 t -79.48 141.35 36.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.184 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 36' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' P' ' 241' ' ' PRO . 18.9 m-85 -107.59 74.69 0.97 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.337 0.589 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 37' ' ' MET . . . . . . . . . . . . . 59.8 tpp -128.68 116.61 19.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.092 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 38' ' ' ASN . . . . . 0.894 ' CG ' ' HB2' ' H' ' 217' ' ' ALA . 47.7 m-80 -108.79 151.83 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.068 0.461 . . . . 0.0 111.786 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 39' ' ' TRP . . . . . 0.425 ' CH2' ' HB2' ' L' ' 23' ' ' CYS . 84.7 m95 -126.04 131.37 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.737 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 40' ' ' TYR . . . . . 0.605 ' HB3' ' HB2' ' L' ' 48' ' ' PRO . 84.4 m-85 -117.37 150.87 38.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.809 0.338 . . . . 0.0 111.233 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 41' ' ' GLN . . . . . 0.831 ' HB2' HD11 ' L' ' 51' ' ' LEU . 59.9 tt0 -117.13 77.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.711 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 42' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -74.87 95.73 2.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.545 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 43' ' ' LYS . . . . . 0.512 ' HB3' ' HD2' ' L' ' 44' ' ' PRO . 57.2 mtpt -69.52 161.07 76.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.598 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 44' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' L' ' 43' ' ' LYS . 9.8 Cg_endo -53.21 99.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.635 2.223 . . . . 0.0 112.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.04 45.69 15.31 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.237 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 46' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' L' ' 43' ' ' LYS . 10.7 tp-100 -155.61 133.99 7.18 Favored Pre-proline 0 C--O 1.234 0.279 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 47' ' ' PRO . . . . . 0.427 ' HD2' ' OE1' ' L' ' 46' ' ' GLN . 7.8 Cg_endo -50.23 142.05 29.68 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.89 2.393 . . . . 0.0 112.738 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 48' ' ' PRO . . . . . 0.663 ' HG3' HD11 ' H' ' 157' ' ' LEU . 18.6 Cg_endo -59.69 109.71 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.078 2.518 . . . . 0.0 113.022 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -72.1 135.74 46.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 50' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' H' ' 217' ' ' ALA . 1.1 tt -77.43 94.17 4.21 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 51' ' ' LEU . . . . . 0.831 HD11 ' HB2' ' L' ' 41' ' ' GLN . 87.8 mt -74.89 -63.11 1.33 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.272 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 52' ' ' ILE . . . . . 0.463 HD11 ' O ' ' L' ' 66' ' ' PHE . 58.3 mt -123.34 145.82 29.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.885 0.374 . . . . 0.0 111.108 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 53' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' H' ' 216' ' ' TYR . 12.7 p90 -134.46 161.76 34.14 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 54' ' ' ALA . . . . . 0.539 ' O ' ' HB3' ' L' ' 55' ' ' ALA . . . 55.78 39.03 30.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 55' ' ' ALA . . . . . 0.674 ' HB2' ' HB3' ' L' ' 35' ' ' SER . . . 82.29 -65.14 0.11 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 56' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' L' ' 68' ' ' GLY . 81.7 p -138.25 18.48 2.77 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 57' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -89.41 100.84 13.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 110.522 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.03 137.39 13.2 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 59' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -85.71 119.94 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.607 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 60' ' ' SER . . . . . . . . . . . . . 51.5 m -52.27 100.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.252 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 61' ' ' GLY . . . . . . . . . . . . . . . 160.71 -44.41 0.41 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.465 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 62' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' L' ' 51' ' ' LEU . 38.4 pt -90.28 159.76 41.23 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-O 120.607 0.242 . . . . 0.0 110.999 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 63' ' ' PRO . . . . . 0.571 ' HB2' ' HG2' ' L' ' 65' ' ' ARG . 28.5 Cg_exo -61.45 167.94 8.87 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.613 2.209 . . . . 0.0 112.078 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.44 39.92 0.86 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 65' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' L' ' 63' ' ' PRO . 47.3 ptt85 -115.3 -3.57 12.47 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 66' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' L' ' 62' ' ' ILE . 97.5 m-85 -100.2 79.8 2.2 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.913 0.387 . . . . 0.0 110.498 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 67' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' L' ' 78' ' ' ASN . 59.9 m -83.94 160.49 21.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 68' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' L' ' 56' ' ' SER . . . -141.71 110.2 0.63 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.317 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 69' ' ' SER . . . . . . . . . . . . . 88.7 p -109.8 114.14 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.784 0.292 . . . . 0.0 110.516 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 70' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' L' ' 75' ' ' PHE . . . -168.36 142.54 7.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.283 -0.96 . . . . 0.0 113.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 71' ' ' SER . . . . . . . . . . . . . 56.4 m -137.01 127.52 26.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.598 0.237 . . . . 0.0 110.661 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 72' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 68.65 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.114 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 73' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' L' ' 25' ' ' ALA . 76.4 p -124.21 -31.8 3.28 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 74' ' ' ASP . . . . . 0.447 ' O ' ' HA2' ' L' ' 70' ' ' GLY . 29.3 t70 -79.86 95.51 6.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.539 0.209 . . . . 0.0 111.157 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 75' ' ' PHE . . . . . 0.573 ' HA ' ' HA3' ' L' ' 70' ' ' GLY . 94.9 m-85 -110.31 159.56 17.32 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.555 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 76' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' L' ' 22' ' ' SER . 88.1 m -154.77 149.66 26.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.936 0.398 . . . . 0.0 111.549 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 77' ' ' LEU . . . . . . . . . . . . . 48.1 tp -111.25 100.1 8.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.289 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 78' ' ' ASN . . . . . 0.506 ' HB2' ' HB2' ' L' ' 67' ' ' SER . 21.0 m120 -86.37 99.59 11.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.874 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 46.8 mt -110.05 81.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 80' ' ' HIS . . . . . 0.734 ' HB3' ' HD3' ' L' ' 81' ' ' PRO . 1.4 t60 -55.42 -64.97 1.66 Allowed Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 81' ' ' PRO . . . . . 0.734 ' HD3' ' HB3' ' L' ' 80' ' ' HIS . 89.3 Cg_endo -82.09 82.74 2.22 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.025 1.817 . . . . 0.0 112.203 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 82' ' ' VAL . . . . . 0.597 HG11 ' CG1' ' L' ' 13' ' ' VAL . 84.1 t -78.0 92.44 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.096 0.474 . . . . 0.0 111.289 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.92 179.99 7.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.237 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -61.35 -26.14 67.62 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.15 -11.47 30.73 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 86' ' ' ASP . . . . . 0.516 ' HB3' HD23 ' L' ' 108' ' ' LEU . 53.2 m-20 -90.54 32.05 0.99 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 87' ' ' ALA . . . . . . . . . . . . . . . -97.18 66.87 2.13 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.97 0.414 . . . . 0.0 110.43 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 88' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' L' ' 43' ' ' LYS . . . -152.8 166.69 31.47 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.38 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 89' ' ' THR . . . . . . . . . . . . . 41.6 m -89.5 125.75 35.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.282 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 90' ' ' TYR . . . . . 0.502 ' HA ' ' O ' ' L' ' 40' ' ' TYR . 63.9 m-85 -97.43 131.4 44.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -122.19 149.25 43.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.776 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 92' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' L' ' 4' ' ' LEU . 9.5 p -116.82 107.27 14.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.285 179.033 51.456 158.488 69.697 103.924 2.027 103.983 134.035 176.075 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 93' ' ' GLN . . . . . 0.505 ' HB2' ' CD2' ' L' ' 102' ' ' PHE . 56.0 tt0 -102.21 120.59 40.72 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.966 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 94' ' ' GLN . . . . . 0.514 ' HG2' ' HB ' ' L' ' 2' ' ' ILE . 4.5 pp0? -87.1 129.0 35.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.364 -0.38 . . . . 0.0 109.994 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 95' ' ' SER . . . . . . . . . . . . . 63.0 p -121.71 41.02 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.73 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 96' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -100.05 -48.22 4.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.889 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 97' ' ' GLU . . . . . 0.563 ' HB3' HD11 ' L' ' 2' ' ' ILE . 35.4 tt0 -129.61 150.76 50.8 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 111.169 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 98' ' ' ASP . . . . . 0.438 ' CG ' ' HA ' ' L' ' 99' ' ' PRO . 17.2 t70 -83.19 144.05 46.35 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' CG ' ' L' ' 98' ' ' ASP . 4.7 Cg_endo -87.32 149.97 36.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 123.922 -1.283 . . . . 0.0 112.1 -0.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -73.18 134.3 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.948 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 101' ' ' THR . . . . . . . . . . . . . 75.2 p -138.1 165.3 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.424 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' HB2' ' L' ' 93' ' ' GLN . 48.3 m-85 -106.68 173.03 6.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.656 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 103' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' L' ' 4' ' ' LEU . . . -92.11 169.03 31.69 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.295 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 104' ' ' SER . . . . . . . . . . . . . 75.6 p -52.64 -30.5 31.94 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.2 158.1 27.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.223 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 106' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' L' ' 9' ' ' ALA . 91.3 m -144.22 91.52 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.644 0.259 . . . . 0.0 111.161 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 107' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -67.47 93.8 0.37 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 108' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' L' ' 86' ' ' ASP . 39.8 tp -80.49 109.83 15.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.859 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 109' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' L' ' 109' ' ' GLU . 0.3 OUTLIER -100.71 108.97 20.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.291 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 110' ' ' ILE . . . . . 0.586 ' C ' HD12 ' L' ' 110' ' ' ILE . 2.3 pp -68.2 160.43 4.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.751 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 111' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' L' ' 14' ' ' SER . 86.8 tttt -129.58 133.63 47.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 112' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' L' ' 112' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.498 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 232' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.859 0.361 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 233' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' P' ' 248' ' ' ILE . 3.0 mmmm -133.12 142.25 48.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.607 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 234' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' P' ' 246' ' ' VAL . 59.5 m -142.92 136.52 28.67 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.65 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 235' ' ' ILE . . . . . . . . . . . . . 8.0 pt -131.69 145.64 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 CA-C-O 121.183 0.516 . . . . 0.0 111.855 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 236' ' ' ARG . . . . . 0.58 ' CZ ' ' HD2' ' H' ' 145' ' ' PRO . 58.2 ttp85 -89.65 110.62 21.49 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 237' ' ' ILE . . . . . 0.496 ' H ' HD13 ' P' ' 237' ' ' ILE . 0.2 OUTLIER -77.1 163.35 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 112.126 -177.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 238' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -99.99 9.98 42.03 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.26 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 239' ' ' ARG . . . . . . . . . . . . . 55.3 mtt-85 -98.04 136.02 38.9 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 240' ' ' GLY . . . . . . . . . . . . . . . -69.79 169.75 44.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.818 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 241' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' L' ' 31' ' ' TYR . 5.7 Cg_exo -76.84 123.99 10.1 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 123.391 -1.504 . . . . 0.0 112.083 -0.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 242' ' ' GLY . . . . . . . . . . . . . . . 69.58 -176.28 32.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.014 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 243' ' ' ARG . . . . . 0.479 ' O ' ' HB1' ' H' ' 215' ' ' ALA . 1.2 mmt180 -111.44 82.45 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 244' ' ' ALA . . . . . 0.443 ' O ' HD13 ' P' ' 237' ' ' ILE . . . -76.28 176.91 7.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.264 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 245' ' ' PHE . . . . . 0.461 ' HE1' HG23 ' H' ' 143' ' ' THR . 2.0 m-85 -112.16 137.83 49.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.431 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 246' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' P' ' 234' ' ' SER . 27.4 m -124.24 125.32 70.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.728 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 247' ' ' THR . . . . . . . . . . . . . 49.4 m -89.35 98.61 11.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 248' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' P' ' 233' ' ' LYS . 35.2 pt -98.55 127.65 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.736 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 249' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 118.518 -1.157 . . . . 0.0 112.924 179.649 . . . . . . . . 0 0 . 1 stop_ save_